Burning Rock Dx

Key Insight Sharing Recently, One article that delved into the boundaries of NGS (Next-Generation Sequencing) in clinical applications. In this article, the author emphasized the natural advantages of NGS, including its ability to explore the unknown and provide comprehensive analysis. As Burning Rock Dx, we will continue to explore the potential of NGS in clinical applications and work towards bridging the gap between research and practice. We are committed to balancing the advantages and limitations of NGS, ultimately paving the way for its successful integration into clinical science and practice. #BurningRockDx #NGS #PrecisionMedicine #ClinicalApplications

A groundbreaking study published in Cell Reports Medicine highlights a new hope for EGFR-mutant NSCLC patients. The study provides supportive data for the utilization of neoadjuvant immunochemotherapy and insight into immune resistance in EGFR-mutant NSCLC. Notably, ctDNA was used as a biomarker to dynamically monitor minimal residual disease, aiding in the identification of patients responding to the treatment. This study, supported by Burning Rock's personalized MRD product, brPROPHET, underscores the importance of preoperative MRD testing in guiding dynamic monitoring and study design for patients with tumor gene mutations. 🔗 Read more: https://lnkd.in/gUDxmraw #LungCancer #CellReportsMedicine #BurningRock

Today, we celebrate the powerful bond between sports, wellness, and healthcare. At Burning Rock Dx, we are dedicated to advancing human health and recognize the pivotal role of physical activity in promoting overall well-being. 🏅🌍 International Olympic Day is a reminder of the positive impact that athletic endeavors have on individual health and community resilience. It highlights values like determination, teamwork, and perseverance—values that align with our mission to enhance lives through innovative diagnostics and personalized healthcare solutions. On this special day, let's embrace the Olympic spirit to promote healthy living and emphasize the importance of integrating sports into healthcare. Together, we can champion a healthier and more active world. Happy International Olympic Day from all of us at Burning Rock Dx! #OlympicDay

Burning Rock Dx Spotlight: OncoCompass® Target   Introducing a Reliable and Evidence-based ctDNA Testing Solution   We are proud to introduce OncoCompass® Target, a CE-certified liquid biopsy tool that sets the standard in ctDNA testing. Backed by rigorous performance validations and extensive research, OncoCompass® Target delivers exceptional accuracy and specificity, ensuring reliable results for targeted therapy and cancer management.   Key Highlights: · Comprehensive Validation: Proven high sensitivity, specificity, and reproducibility. · Extensive Research: Over 90 papers published since 2020. · Clinical Utility: Supports targeted therapy, immuno-oncology, and germline specific gene analysis. Stay tuned as we dive deeper into some of the groundbreaking research supporting OncoCompass® Target. For more information, feel free to reach out to us at PBD@brbiotech.com.   #LiquidBiopsy #ctDNA #BurningRockDx

Our colleague Chun (Michael) Chen , PharmD, is presenting today at the Immuno-Oncology hubXchange conference in Boston! 🎤✨ His keynote topic is: "Exploring the potential: harnessing ctDNA MRD in immune-oncology treatment for solid tumors." Our team members will be at the conference all day, eager to engage with all attendees. Looking forward to discussing the latest advancements in immuno-oncology! If you're at the event, be sure to connect with us! #ImmunoOncology #BurningRockDx #ctDNA #MRD

Happy Father's Day from Burning Rock Dx! This Father's Day, let's prioritize the health and well-being of our dads. With OverC™ Multi-Cancer Detection Blood Test, we offer a revolutionary early detection for 5 cancer types. One tube of blood can make a big difference. 🩺 Health Tips for Dad: › Stay active: Enjoy physical activities like walking, golf, or gardening. › Eat well: Focus on a balanced diet with fruits, vegetables, lean proteins, and whole grains. › Regular check-ups: Ensure regular health check-ups and screenings. › Mental well-being: Remember the importance of mental health and seek support when needed. Celebrate this special day by ensuring your dad's health and happiness! #FathersDay #EarlyCancerDetection #BurningRockDx

We are excited to share that Chun (Michael) Chen, PharmD, from Burning Rock Dx, will be presenting at the Immuno-Oncology Xchange run by hubXchange Join us for his keynote presentation titled: "Exploring the potential: harnessing ctDNA MRD in immune-oncology treatment for solid tumors." 🗓 Date: June 18, 2024 🕒 Time: 8:30 - 9:00 AM 📍 Woburn Hilton Hotel, Boston MA 01801 In addition, our talented team members ，Shawn A. , Alex Brand and Liliang Jin will also be attending the conference. This is a fantastic opportunity to connect and discuss the latest advancements in immuno-oncology. #ImmunoOncology #CancerResearch #BurningRockDx #ctDNA #MRD

📊 Top Oncology Companies in 2025 👇 📈 American Society of Clinical Oncology (ASCO) ended last week with impressive data notably from Summit Therapeutics, Inc., Merus N.V., Pfizer, and AstraZeneca. 📊 Let's remember that nearly 10 million people die of cancer annually with leading causes of cancer death being lung, colorectal, and liver cancer. ⏳ As life expectancy improves the odds of eventually getting cancer go up. The demand for cancer therapeutics will likely rise disproportionately to overall pharma spending for several decades. 📉 Innovation is crucial and much needed for patients. Pancreatic cancer survival time has improved by over 150% since first diagnosis. Liver and lung improved by over 75%. 😔 Brain cancer, larynx cancer, melanoma, and thyroid cancer survival times have for now not significantly improved. 💡 Top oncology companies are today Merck, Bristol Myers Squibb, and Roche, but by 2030, Johnson & Johnson, and AstraZeneca are expected to lead. 🚀 Daiichi Sankyo is forecasted to rise the most in the coming years thanks to its expected Antibody Drug Conjugates (ADCs) success. 🔎 Let's have a look at the forecasted top players of the oncology innovation in 2025 based on estimates from Stifel Research, Evaluate Ltd, and Analysts' reports. Get the Latest Pharma Industry Updates directly in your inbox by subscribing to the newsletter - link in the comment section 👇

Burning Rock Dx Spotlight: brPROPHET We're excited to highlight the latest advancements in our MRD detection product, brPROPHET, showcased at the recent ASCO conference! Since its market launch on March 1, 2022, brPROPHET has been empowering precision clinical research. Here's what we've achieved so far: 1. Featured in 12 posters at AACR, ASCO, and ESMO 2. Published a paper in Cancer Cell Discover more about brPROPHET and its groundbreaking impact on MRD detection. For detailed information, check the attachment or contact us at PBD@brbiotech.com. Stay tuned for more exciting results coming soon! #MRD #PrecisionMedicine #BurningRockDx

🌍 World Environment Day: Our Commitment to Sustainability On this World Environment Day, Burning Rock Dx reaffirms our dedication to environmental sustainability. Our mission is to drive advancements in medical technology while championing sustainable practices. 🚀 Our Key Initiatives: 1. Greenhouse Gas Inventory: Verified under ISO 14064-3:2019. 2. Global Platforms: Active on EcoVadis and CDP (Carbon Disclosure Project). 3. Science-Based Targets Initiative（SBTi）: Committed to the SBTi, with emission reduction targets under review. We are committed to transparency, social value, and responsibility for our planet's future. Together, let's build a sustainable world through innovation and responsible practices. #WorldEnvironmentDay #Sustainability #BurningRockDx